Tagraxofusp

Elzonris 1 MG/ML Concentrado Para Solucion Para Perfusion

1 mg/ml concentrado para solución para perfusiónSpainAuthorisedAuthorised 20 Oct 2023

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

ElzonrisEuropean UnionAuthorised

ElzonrisEuropean Union · Stemline Therapeutics B.V.Same brand
ElzonrisCroatiaSame brand
ElzonrisItaly · Concentrato per soluzione per infusione · Stemline Therapeutics BVSame brand
ELZONRIS 1 mg/ml, oplossing voor infusieNetherlands · Oplossing voor infusie · TMC Pharma (EU) LimitedSame brand
Elzonris Concentrate for Solution for Infusion 1000 MCG/MLSingapore · 1.0 MG/mL · infusion, solution concentrate · A. Menarini Singapore Pte. LTD.Same brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Tagraxofusp

Elzonris 1 MG/ML Concentrado Para Solucion Para Perfusion

1 mg/ml concentrado para solución para perfusiónSpainAuthorisedAuthorised 20 Oct 2023

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

ElzonrisEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

ElzonrisUnited States · 1000MCG · solution · Stemline Therapeutics INC

Packs

Pack	Code	Status
ELZONRIS 1 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial	763623

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Tagraxofusp
Strength: 1 mg/ml
Dosage form: concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 20 Oct 2023
Registration: 1201504001
Marketing authorisation holder: Stemline Therapeutics B.V.
Procedure: EU centralised
Supply: Uso Hospitalario
EU number: EU/1/20/1504